Jude E. Onyia
Eli Lilly (Singapore)(SG)
Publications by Year
Research Areas
Bone Metabolism and Diseases, Bone health and treatments, Cell Adhesion Molecules Research, Protein Kinase Regulation and GTPase Signaling, Gene expression and cancer classification
Most-Cited Works
- → Ghrelin octanoylation mediated by an orphan lipid transferase(2008)801 cited
- → Catabolic Effects of Continuous Human PTH (1–38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation(2001)429 cited
- → EphrinB2 Regulation by PTH and PTHrP Revealed by Molecular Profiling in Differentiating Osteoblasts(2008)200 cited
- → The Osteoblast-specific Transcription Factor Cbfa1 Contributes to the Expression of Osteoprotegerin, a Potent Inhibitor of Osteoclast Differentiation and Function(2000)183 cited
- → Orally Bioavailable GSK-3α/β Dual Inhibitor Increases Markers of Cellular Differentiation In Vitro and Bone Mass In Vivo(2006)179 cited
- → Stimulation of Osteoprotegerin (OPG) Gene Expression by Transforming Growth Factor-β (TGF-β)(2001)142 cited
- → Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarray(2005)96 cited
- → Activation of Osteocalcin Transcription Involves Interaction of Protein Kinase A- and Protein Kinase C-dependent Pathways(2000)93 cited
- → Nuclear Matrix Proteins and Osteoblast Gene Expression(1998)78 cited
- → Cloning and Functional Analysis of a Family of Nuclear Matrix Transcription Factors (NP/NMP4) that Regulate Type I Collagen Expression in Osteoblasts(2001)70 cited